|
Timothy Miller, MD, PhD
Washington University in St. Louis
Tuesday, October 29, 2019
1:00 - 2:00 PM EDT
Novel gene-targeted therapies are being developed for ALS and other neurodegenerative diseases. We will discuss how these drugs work and some of the research driving these clinical trials.
|
